Compound ID | 3132
Synonym(s): QPX-7831 | QPX 7831 | Compound 5-Na
Class: Beta-lactamase inhibitor
Spectrum of activity: | Gram-negative |
Details of activity: | Active against class A and class C enzymes from Enterobacterales, and class B metalloenzymes (NDM-1) and class D enzymes from Acinetobacter spp. |
Description: | Synthetic compound; shows no intrinsic antibacterial activity |
Institute where first reported: | Qpex Biopharma, San Diego, California, United States |
Year first mentioned: | 2021 |
Highest developmental phase: | Phase 1 (NCT04578873, NCT06157242, NCT06079775) |
Development status: | Active |
Chemical structure(s): | |
Canonical SMILES: | CC(C)C(=O)OCOC(=O)C1=C2C(=CC=C1F)[C@H]3C[C@H]3B(O)O2 |
Isomeric SMILES: | B1([C@@H]2C[C@@H]2C3=C(O1)C(=C(C=C3)F)C(=O)OCOC(=O)C(C)C)O |
InChI: | InChI=1S/C15H16BFO6/c1-7(2)14(18)21-6-22-15(19)12-11(17)4-3-8-9-5-10(9)16(20)23-13(8)12/h3-4,7,9-10,20H,5-6H2,1-2H3/t9-,10-/m1/s1 |
InChI Key: | FCXHIXHOQJYLTG-NXEZZACHSA-N |
Structure link: | https://pubchem.ncbi.nlm.nih.gov/compound/156858930 |
External links: | |
Guide to Pharmacology: | xeruborbactam isoboxil |
Main Source: | https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c01722 |